GP Capital
China chatbot developer raises funding to ride ChatGPT wave
Emotibot, a China-based chatbot developer, has raised a Series D extension of undisclosed size from GP Capital, KYMCO Capital, Jiangsu Cultural Investment, and Junci Investment.
China hydrogen energy player raises $44m Series C
Chinese hydrogen power company TangFeng Energy has raised a Series C round of CNY300m (USD 44m) led by GP Capital, Qianyan Investment, and a unit of Dongfeng Motor Corporation.
Boyu, Confitop lead pre-IPO round for China pet food player
Shandong Seek Pet Products, a China-based pet food manufacturer, has raised nearly CNY 500m (USD 75m) in pre-IPO funding led by Boyu Capital and Confitop Capital.
China AR glasses maker Nreal gets $100m Series C
Nreal, a Chinese manufacturer of advanced artificial reality (AR) glasses that resemble normal sunglasses, has raised a Series C of $100 million led by Nio Capital, Yunfeng Capital, and Hongtai Capital.
CPE joins Series D for China biotech player TransThera
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.
CITIC entities commit $94m to China's Simcere Diagnostics
SimCere Diagnostics, the diagnostics arm of Hong Kong-listed SimCere Pharmaceutical Group, has raised RMB600 million ($94 million) in Series B funding led by CITIC Securities and CITIC Medical & Health Fund.
China's Cloopen, Adagene complete strong US IPOs
Cloud services provider Cloopen and biotech developer Adagene, both backed by Sequoia Capital China, have raised a combined $460 million in their US IPOs.
China mixed reality player Nreal secures $40m Series B
Nreal, a Chinese manufacturers of advanced virtual reality glasses that resemble normal sunglasses, has raised $40 million in Series B funding led by local video sharing platform Kuaishou.
China’s BeauCare Clinics secures $29m Series B
BeauCare Clinics, a Chinese plastic surgery clinic chain, has raised RMB200 million ($29 million) in a Series B round of funding led by GP Capital.